In particular, HIF2α activation, which occurs in the livers of patients with NAFLD as well as in mouse models (3), appears to worsen lipid accumulation (see Figure 2). The gene discussed is EPAS1; the disease is metabolic dysfunction-associated steatotic liver disease.